Salidroside protects against bleomycin-induced pulmonary fibrosis: activation of Nrf2-antioxidant signaling, and inhibition of NF-κB and TGF-β1/Smad-2/-3 pathways

Oxidative Stress and Antioxidant Defense

Esra Birben, Ümit Murat Şahiner, Cansın Saçkesen et al. · World Allergy Organization Journal · 2012 · 4.9K citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Luca Richeldi, Roland M. du Bois, Ganesh Raghu et al. · New England Journal of Medicine · 2014 · 4.6K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King, Williamson Z. Bradford, Socorro Castro-Bernardini et al. · New England Journal of Medicine · 2014 · 3.9K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Alveolar epithelial cell mesenchymal transition develops <i>in vivo</i> during pulmonary fibrosis and is regulated by the extracellular matrix

Kevin K. Kim, Matthias C. Kugler, Paul J. Wolters et al. · Proceedings of the National Academy of Sciences · 2006 · 1.2K citations · Full text

Life Sciences, Cell Biology, Pathobiology +17

Salidroside Attenuates Ventilation Induced Lung Injury via SIRT1-Dependent Inhibition of NLRP3 Inflammasome.

PubMed · 2017 · 821 citations

Life Sciences, Pathobiology, Pharmacology +17